The expression profile of EBNA 1-3 and LMP1 confirmed that both of our DLBCL PDXs (KUC4 and KUC11) were latency type III lymphoma, which is observed in the patients under severe immunodeficient state. The gene discussed is PDLIM7; the disease is diffuse large B-cell lymphoma.